News

News Filters

NHIF: Supporting home infusion

The National Home Infusion Foundation (NHIF) invests in and performs research as well as recognizes and supports outstanding home infusion professionals and their work.
SITE: nhia
NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.
SITE: nhia
The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.
SITE: nhia
Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.
SITE: nhif
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2025 Outstanding Abstract Achievement Award (OAAA) is Leslie Myers, PharmD, IgCP of CSI Pharmacy.
SITE: nhia
The National Home Infusion Association has announced the finalists for its 2025 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
SITE: nhia
NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.
SITE: nhia
The National Home Infusion Association (NHIA) is proud to announce that Mitra Gavgani, PharmD is the recipient of the 2025 Gene Graves Lifetime Achievement Award.
SITE: nhia
The National Home Infusion Association (NHIA) applauds the re-introduction of The Preserving Patient Access to Home Infusion Act – bipartisan, bicameral legislation that will ensure Medicare patients can receive the intravenous (IV) medications they need while at home.
SITE: nhif
NHIF is proud to announce that Maritza DeGagne, RPh is the recipient of the 2025 Lynn Giglione Women in Leadership Award, which recognizes and honors trail-blazing and emerging women leaders who have demonstrated exemplary service to patients and their peers while promoting the mission of NHIF.
SITE: nhif
The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.
SITE: nhif
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
SITE: nhia
NHIA submitted comments to CMS on its Draft Medicare Transaction Facilitator (MTF) Agreements, which will be used to implement negotiated prices for drugs under the Medicare Drug Price Negotiation Program.
SITE: nhia
NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level.
SITE: nhia
The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.
SITE: nhia
An independent analysis by Magnolia Market Access estimates that changes proposed by NHIA to the Preserving Patient Access to Home Infusion Act to expand Medicare Part B home infusion therapy services coverage to anti-infectives, and bundle payments for disposable supplies with the services payment would generate significant savings for Medicare.

NHIA Comments on MTF for 2026 and 2027

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »

NHIA Announces Greg LoPresti to Lead Board of Directors

The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.

Read More »

NHIA 2025 Features Largest Home Infusion Expo & Builds a Roadmap for Progress

Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Read More »

Pentec Health and Vital Care Infusion Services to Join NHIA Board of Directors

NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.

Read More »

NHIA Announces 2025 Class of Fellows

The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.

Read More »

NHIF Announces Finalists for 2025 Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.

Read More »

Call for NHIA Board Member Candidates

NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level.

Read More »

Congressional Spending Bill Falls Short on Home Infusion

The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.

Read More »

Melinta Joins NHIA Future of Infusion Advisory Council

The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC).

Read More »

Patient, Stakeholder Groups Urge Congress to Address Medicare’s Failed Home Infusion Benefit

A diverse group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 1976/H.R. 4104) and increase access to home infusion therapy for Medicare beneficiaries.

Read More »

NHIA Comments on MTF for 2026 and 2027

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »

NHIA Announces Greg LoPresti to Lead Board of Directors

The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.

Read More »

NHIA 2025 Features Largest Home Infusion Expo & Builds a Roadmap for Progress

Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Read More »

Pentec Health and Vital Care Infusion Services to Join NHIA Board of Directors

NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.

Read More »

NHIA Announces 2025 Class of Fellows

The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.

Read More »

NHIF Announces Finalists for 2025 Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.

Read More »

Call for NHIA Board Member Candidates

NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level.

Read More »

Congressional Spending Bill Falls Short on Home Infusion

The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.

Read More »

Melinta Joins NHIA Future of Infusion Advisory Council

The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC).

Read More »

Patient, Stakeholder Groups Urge Congress to Address Medicare’s Failed Home Infusion Benefit

A diverse group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 1976/H.R. 4104) and increase access to home infusion therapy for Medicare beneficiaries.

Read More »